NASDAQ:BBI Brickell Biotech (BBI) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.77▼$0.9352-Week Range N/AVolume31,300 shsAverage Volume206,730 shsMarket Capitalization$6.75 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Brickell Biotech alerts: Email Address Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> About Brickell Biotech Stock (NASDAQ:BBI)Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.Read More Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> BBI Stock News HeadlinesOctober 19, 2023 | bizjournals.comBrickell hotel sold by royal family member for $55MAugust 27, 2023 | dailymail.co.ukPaul Simon and Edie Brickell's daughter speaks out following parents' arrestJuly 26, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.April 25, 2023 | bizjournals.comSeattle Biotech NewsApril 10, 2023 | marketwatch.comNuclear Receptor ROR-Gamma Market Size by 2030March 29, 2023 | travel.usnews.comBrickell City CentreMarch 24, 2023 | bizjournals.comBiotech NewsMarch 18, 2023 | techcrunch.com5 strategies for biotech startups to outlast a market downturnJuly 26, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.March 14, 2023 | marketwatch.comNuclear Receptor ROR-Gamma Market Application, Product, Sales and Forecast 2023-2028February 27, 2023 | finance.yahoo.comWhat Sunzen Biotech Berhad's (KLSE:SUNZEN) P/E Is Not Telling YouFebruary 27, 2023 | techcrunch.comBiotech proved a surprisingly bright spot in 2022’s startup correctionFebruary 21, 2023 | msn.comPaul Simon Was 50 When He Married a 26-Year-Old Edie BrickellFebruary 19, 2023 | cnbc.comThis biotech hedge fund has elite clients like Yale’s endowment, Tisch. Here are its top betsFebruary 10, 2023 | benzinga.comBest Biotech Penny StocksJanuary 13, 2023 | markets.businessinsider.comVERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery SystemJanuary 9, 2023 | cbsnews.comUSDA approves vaccine for honeybees, biotech company saysJanuary 4, 2023 | marketwatch.comBioreactors and Fermenters Market 2023 Expected to Witness the Highest Revenue Growth Over Forecast to 2028See More Headlines Receive BBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brickell Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/11/2022Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological Products, Except Diagnostic Sub-IndustryN/A Current SymbolNASDAQ:BBI CUSIPN/A CIK819050 Webwww.brickellbio.com Phone(720) 505-4755Fax858-646-1150Employees16Year Founded2009Profitability EPS (Most Recent Fiscal Year)($13.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-39,470,000.00 Net Margins-643.48% Pretax Margin-643.48% Return on Equity-156.10% Return on Assets-128.23% Debt Debt-to-Equity RatioN/A Current Ratio6.36 Quick Ratio6.36 Sales & Book Value Annual Sales$4.64 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$9.75 per share Price / BookN/AMiscellaneous Outstanding Shares2,874,000Free Float2,744,000Market Cap$6.75 million OptionableNot Optionable Beta0.02 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Reginald L. Hardy M.B.A. (Age 64)R.Ph., Co-Founder & Chairman Comp: $76.83kAttorney Robert Busard Brown (Age 60)CEO & Director Comp: $816.73kMr. Andrew D. Sklawer (Age 38)Co-Founder, Pres, COO & Sec. Comp: $559.58kMr. Deepak Chadha M.B.A. (Age 52)M.S., MBA, MS, RAC, Chief R&D Officer Comp: $543.59kMr. Albert Nicholas Marchio II (Age 70)CFO and Principal Accounting & Financial Officer Mr. David R. Mcavoy J.D. (Age 59)Gen. Counsel & Chief Compliance Officer Mr. Gary S. Walker (Age 62)Chief Marketing Officer Aron Aizenstat M.B.A.P.M.P., VP of Corp. Devel. & OperationsMs. Sue FattorHead of Human ResourceMs. Nancy SerettaVP & Head of Clinical OperationsMore ExecutivesKey CompetitorsSAB BiotherapeuticsNASDAQ:SABSBrainstorm Cell TherapeuticsNASDAQ:BCLICortexymeNASDAQ:CRTXAIM ImmunoTechNYSE:AIMPharmaCyte BiotechNASDAQ:PMCBView All Competitors BBI Stock Analysis - Frequently Asked Questions How were Brickell Biotech's earnings last quarter? Brickell Biotech, Inc. (NASDAQ:BBI) posted its earnings results on Thursday, August, 11th. The company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($1.48) by $1.47. Brickell Biotech had a negative net margin of 643.48% and a negative trailing twelve-month return on equity of 156.10%. When did Brickell Biotech's stock split? Brickell Biotech shares reverse split on Tuesday, July 5th 2022. The 1-45 reverse split was announced on Tuesday, July 5th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 5th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. What other stocks do shareholders of Brickell Biotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Brickell Biotech investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (vbiv), Jaguar Health (JAGX), Miragen Therapeutics (MGEN), Acasti Pharma (ACST), Allena Pharmaceuticals (ALNA) and Aileron Therapeutics (ALRN). This page (NASDAQ:BBI) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brickell Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Brickell Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBI Stock Alerts